The Centre has partnered with MMV as a Product Development Partnership. The Australian Government’s partnership with MMV began in 2015, with the PDP receiving $10 million over three years to 2018. In 2017 an independent review found that DFAT’s investment in PDPs, through core funding, represented good value for money and that MMV’s innovations had made significant contributions to malaria elimination globally and in Australia’s region.
Following the recommendations of the 2017 review, the Health Security Initiative invested an additional $18.5 million in MMV under the $75 million Product Development Partnership Fund.
Although a small organisation, MMV has a broad reach internationally, both in the Asia Pacific region and elsewhere. Australia’s continued and visible support of MMV demonstrates the reach, the concern and the engagement of the country in combatting a disease of world-wide concern.